Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $1.96 Million - $2.95 Million
-16,721 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$126.46 - $235.05 $871,182 - $1.62 Million
6,889 Added 70.07%
16,721 $2.88 Million
Q4 2021

Feb 15, 2022

SELL
$225.82 - $368.51 $129,846 - $211,893
-575 Reduced 5.53%
9,832 $2.5 Million
Q3 2021

Nov 16, 2021

BUY
$221.9 - $484.47 $2.31 Million - $5.04 Million
10,407 New
10,407 $4.01 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kiwi Wealth Investments Limited Partnership Portfolio

Follow Kiwi Wealth Investments Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.